EXCLUSIVE: Pasithea Therapeutics’s Subsidiary Pasithea Clinics Announces Successful Treatment Of First Patients In The UK With Ketamine Infusion Therapy
Miami Beach, FL / October 27, 2021 -- Pasithea Therapeutics Corp. (Nasdaq:
KTTA) (“Pasithea” or the “Company”), a novel biotechnology company focused
on the research and discovery of new and